Preclinical evaluation of cancer drugs
The discovery that a certain molecule could be used as a new therapeutic against a certain cancer type is often made in the lab. However, before new medicines based on these molecules can be used to treat patients, they need to be extensively tested and validated. Many CRIG studies are focused on this pre-clinical aspect of cancer research and thereby bridge the gap between basic research and clinical practice.
CRIG group leaders
Other CRIG members
- dr. Inna Afonina (PhD)
- Eva Blondeel
- dr. Delfien Bogaert (MD, PhD)
- Helena Braet
- Nathan Carpentier
- dr. Dorien Clarisse (PhD)
- dr. Sarah Cosyns (PhD)
- Martijn de Jong
- Els De Smet
- dr. Elly De Vlieghere (PhD)
- Fanny De Vloed
- Jolien De Wyn
- dr. Bieke Decaesteker (PhD)
- Jill Deleu
- Larissa Deneweth
- Lisa Depestel
- dr. Benedicte Descamps (PhD)
- prof. Lindsey Devisscher (PhD)
- Inge D'Hont
- prof. Matthias D’hooghe (PhD)
- Aline Eggermont
- Sam Ernst
- Charlotte Fieuws
- dr. Behrouz Hassannia (PhD)
- dr. Els Janssens (PhD)
- dr. Lore Lapeire (MD, PhD)
- dr. Sander Lefere (MD)
- dr. Kai Ling Liang (PhD)
- Siebe Loontiens
- Amber Louwagie
- Christophe Mangodt
- dr. Filip Matthijssens (PhD)
- dr. Pieterjan Merckx (PhD)
- dr. Valerie De Meulenaere (PhD)
- dr. Liselot M. Mus (PhD)
- dr. Viacheslav Mylka (PhD)
- dr. Parisa Norouzitallab (PhD)
- Carolina Nunes
- dr. Bogdan Parakhonskiy (PhD)
- dr. Tim Pieters (PhD)
- Lien Provez
- Muhammad Rishfi
- dr. Bart Roman (PhD)
- Ellen Sanders
- prof. Jens Staal (PhD)
- dr. Jonas Steenbrugge (PhD)
- Eva Terras
- dr. Laurens Van Camp (MD)
- Leen Van de Sande
- Stephane Van Haver
- prof. Jolanda van Hengel
- Jolien Van Laere
- dr. Sandra Van Lint (PhD)
- Maaike Van Trimpont
- Katrien Vandemeulebroecke
- Jolien Vanhooren
- prof. Christian Vanhove (PhD)
- dr. Rein Verbeke (PhD)
- dr. Jeroen Verhoeven (PhD)
- Nurten Yigit